BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Eksigent Technologies Release: ExpressHT(TM)-Ultra HPLC System Delivers High Throughput for Bioanalysis


12/12/2008 1:53:51 PM

Dublin, CA, December 11, 2008 – Eksigent, a developer of advanced low-flow fluid delivery technologies for drug discovery and other life science applications, introduces the ExpressHT™-Ultra HPLC system, providing short cycle times and high throughput for LC/MS studies of pharmacokinetics and drug metabolism. This new system is the latest offering in the company’s line of products for small molecule analysis. With cycle times as short as 60 seconds, the ExpressHT-Ultra can run six 96-well sample plates overnight.

Running at a maximum pressure of 10,000 psi, the system enables the use of small particle stationary phases to deliver narrow peaks to the mass spectrometer. Employing columns with diameters of 1 mm or smaller, the Express HT-Ultra uses up to 95 percent less solvent per analysis than traditional HPLC systems, helping customers meet green initiative goals and reduce purchase and disposal costs.

“Drug discovery and development researchers need a higher throughput LC solution to process ever-increasing numbers of samples,” said David Neyer, Ph.D., product manager for Eksigent. “Our proprietary technology delivers fast separations at low flow rates to meet the growing demands of LC/MS applications.”

Eksigent’s proprietary Microfluidic Flow Control (MFC) technology generates accurate and reproducible flow rates from nanoliters per minute to hundreds of microliters per minute. The Eksigent control software includes integrated drivers for the most widely used mass spectrometry programs including Applied Biosystems/MDS SCIEX Analyst*, Thermo Scientific Xcalibur* and Bruker Daltonics HyStar*.

Eksigent serves the life science, drug discovery and pharmaceutical industries, expanding customer possibilities with low-flow fluid delivery solutions. From precise separation of precious samples in proteomics research to fast and efficient analytical chromatography to unique medical devices that improve the way drugs are delivered, Eksigent brings novel solutions to customer challenges. The company combines proprietary microfluidic pumping technology with creative approaches that help customers improve productivity and expand their research and market opportunities. Eksigent serves customers throughout the world, including Europe, Asia and Australia, through a growing sales and service network. For more information, visit www.eksigent.com.

*All trademarks are the property of their respective owners.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->